Form 4 for ATYR aTYR PHARMA INC
Accepted 2026-02-04 00:00:00 ET · period of report 2026-02-03 · accession 0001193125-26-037996 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-04 | 2026-02-03 | ATYR | DENYES NANCY | GC | M - OptEx | — | +2,687 | 34.2K | +9% | — |
| D | 2026-02-04 | 2026-02-04 | ATYR | DENYES NANCY | GC | S - Sale+OE | $0.98 | -1,118 | 33.1K | -3% | -$1,096 |
| D | 2026-02-04 | 2026-02-03 | ATYR | DENYES NANCY | GC | M - OptEx | $0.00 | -2,687 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-03 | M | A | 2,687 | — | 34,242 | D | — | — | (F2) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2026-02-04 | S | D | 1,118 | $0.98 | 33,124 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-02-03 | M | D | 2,687 | $0.00 | 0 | D | — · — to — | 2,687 Common Stock | (F2) Restricted stock units convert into common stock on a one-for-one basis. (F4) The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. |